Data protection Impressum

Medtech

As life sciences companies navigate increasingly complex global markets, the decision of where to establish or expand international operations has become a strategic one.

Why Switzerland

Why Life Sciences Companies Choose Switzerland to Scale Internationally

Renens-based L.E.S.S. SA has raised CHF 17 million to accelerate the industrial-scale deployment of its proprietary LuxiBright nano-fiber lighting technology across automotive, machine vision, and medical markets.

L.E.S.S. SA raises CHF 17 million to scale its nano-fiber lighting technology

3 March 2026

Bracco Imaging, Limula, and the University of Fribourg have launched an Innosuisse-funded research partnership to automate and reduce the cost of CAR-T cell therapy production.

Bracco, Limula and the University of Fribourg join forces to lower the cost of cell therapies

3 March 2026

Geneva-based Clee Medical has raised Seed funding to accelerate clinical validation of its Neuro Access imaging technology for minimally invasive neurosurgery.

Clee Medical secures financing to advance real-time brain imaging platform

25 February 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (February 2026)

25 February 2026

Three Western Switzerland cleantech and medtech start-ups have received FIT support to scale geothermal panels, rapid bacteria detection and carbon capture filters.

FIT backs Enerdrape, Bioneris and Divea with growth and seed loans

24 February 2026

Swiss start-ups raised CHF 2.9 billion in 2025, marking a strong recovery in venture capital investment led by ICT and biotech.

Swiss start-ups attract CHF 2.9 billion in 2025 as venture capital rebounds

3 February 2026

SamanTree Medical has secured EUR 20 million from the European Investment Bank to expand its surgical imaging technology across Europe and the United States and accelerate product development.

SamanTree Medical secures EUR 20 million to scale surgical imaging technology

2 February 2026

The Fonds pour l’Innovation et le Futur de Genève (FIF) has awarded CHF 50,000 grants to three academic spin-off projects from Geneva, supporting innovation in medical technology, scientific instrumentation, and gene therapy.

FIF awards grants to three Geneva-based academic spin-offs

29 January 2026

Researchers from the Francis Crick Institute and Bern-based AlveoliX have developed the first human lung-on-chip model built entirely from genetically identical cells, opening new perspectives for personalised respiratory disease research.

AlveoliX contributes to first lung-on-chip model using genetically identical human cells

19 January 2026

1 2 3 4 5 6 … 15